StockClub

CBIO

CBIOCrescent Biopharma, Inc.$ --
Crescent Biopharma, Inc.

Crescent Biopharma, Inc.

CBIO

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
1M USD
YoY +Infinity%
Operating Income
-25M USD
YoY -73.9%
Net Income
-23M USD
YoY -53.7%
EPS
-0.7$
YoY +10.3%

Revenue

$1M
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$10.8M
$10.8M
Q4
FY2026 Q1$1M
$1M
Q1
Actual
+$1M (-)

Net Income

$-23.3M
FY2024 Q2$-20.8M
$-20.8M
Q2
FY2024 Q3$-30.7M
$-30.7M
Q3
FY2024 Q4$-48.5M
$-48.5M
Q4
FY2025 Q1$-15.1M
$-15.1M
Q1
FY2025 Q2$-36.9M
$-36.9M
Q2
FY2025 Q3$-61.5M
$-61.5M
Q3
FY2025 Q4$-153.9M
$-153.9M
Q4
FY2026 Q1$-23.3M
$-23.3M
Q1
Actual
$-8.1M (-53.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$10.2M
Est:$10M
FY2020BEAT
$10.2M
FY2021BEAT
Actual:$1.2M
Est:$835,500
FY2021BEAT
$1.2M
FY2022BEAT
Actual:$75,000
Est:$66,667
FY2022BEAT
$75,000
FY2023
Actual:$10,000
FY2023
$10,000
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025BEAT
Actual:$10.8M
Est:$7.5M
FY2025BEAT
$10.8M

Analyst Estimates